Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-26 @ 12:26 AM
Study NCT ID:
NCT03506360
Status:
COMPLETED
Last Update Posted:
2024-01-09
First Post:
2018-04-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-10
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-11
First Submit QC Date:
None
Study First Post Date:
2018-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-10-19
Results First Submit QC Date:
None
Results First Post Date:
2022-11-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-04
Last Update Post Date:
2024-01-09
Last Update Post Date Type:
ACTUAL